Actein has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis, it also can prevent oxidative damage to osteoblasts in osteoporotic patients. Acteins ability to pathways involved in lipid disorders and carcinogenesis may make it a new agent for preventing and treating these major disorders, it has been shown to inhibit the proliferation of human breast cancer cells, by altering the activity of the ER IP3 receptor and Na,K-ATPase, inducing calcium release and modulating the NF-kB and MEK pathways.
Molecular Weight:
676.83
Purity:
98%
CAS Number:
[18642-44-9]
Formula:
C37H56O11
Target:
Akt|||ROS|||Apoptosis|||Autophagy|||JNK
T7190
* VAT and and shipping costs not included. Errors and price changes excepted
